Enliven Therapeutics (ELVN) Cash & Equivalents (2019 - 2026)
Enliven Therapeutics (ELVN) reported Cash & Equivalents of $135.51 million for Q2 2026, up 13.5% from $119.44 million a year earlier and up 2.5% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Enliven Therapeutics posted Cash & Equivalents of $98.9 million, down 20.3% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $124.12 million in FY2024 (+23.9%), $100.14 million in FY2023 (+32.6%), $75.54 million in FY2022 (+56.4%) and $48.31 million in FY2021 (+1.3%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents since Q1 2024.
- Year over year, Cash & Equivalents gained in six of the last eight quarters, with growth averaging 9.5%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2023 (growth of 192.5%); the low point was Q1 2024 (a decline of 48.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $132.18 million (Q1 2026), $98.9 million (Q4 2025) and $101.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Enliven Therapeutics | 3.44 Bn | 3.44 Bn | - | 135.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 135.51 Mn |
| Mar 31, 2026 | 132.18 Mn |
| Dec 31, 2025 | 98.90 Mn |
| Sep 30, 2025 | 101.73 Mn |
| Jun 30, 2025 | 119.44 Mn |
| Mar 31, 2025 | 101.71 Mn |
| Dec 31, 2024 | 124.12 Mn |
| Sep 30, 2024 | 100.62 Mn |
| Jun 30, 2024 | 96.87 Mn |
| Mar 31, 2024 | 149.17 Mn |
| Dec 31, 2023 | 100.14 Mn |
| Sep 30, 2023 | 73.85 Mn |
| Jun 30, 2023 | 125.72 Mn |
| Mar 31, 2023 | 292.10 Mn |
| Dec 31, 2022 | 75.54 Mn |
| Sep 30, 2022 | 86.16 Mn |
| Jun 30, 2022 | 92.46 Mn |
| Mar 31, 2022 | 99.88 Mn |
| Dec 31, 2021 | 48.31 Mn |
| Sep 30, 2021 | 75.30 Mn |
API Access
Enliven Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();